ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $369,000 | -21.3% | 29,680 | -13.3% | 0.01% | -22.2% |
| Q3 2016 | $469,000 | +87.6% | 34,230 | +1.4% | 0.01% | +80.0% |
| Q2 2016 | $250,000 | -4.2% | 33,770 | -17.2% | 0.01% | -16.7% |
| Q1 2016 | $261,000 | -12.4% | 40,770 | -14.6% | 0.01% | 0.0% |
| Q4 2015 | $298,000 | -9.7% | 47,720 | -15.6% | 0.01% | -14.3% |
| Q3 2015 | $330,000 | -22.5% | 56,520 | +9.7% | 0.01% | -12.5% |
| Q2 2015 | $426,000 | -3.8% | 51,520 | -4.3% | 0.01% | 0.0% |
| Q1 2015 | $443,000 | +15.4% | 53,820 | -3.8% | 0.01% | 0.0% |
| Q4 2014 | $384,000 | +14.6% | 55,920 | -10.0% | 0.01% | +14.3% |
| Q3 2014 | $335,000 | -16.5% | 62,120 | -1.2% | 0.01% | -12.5% |
| Q2 2014 | $401,000 | -7.8% | 62,890 | +16.4% | 0.01% | 0.0% |
| Q1 2014 | $435,000 | +103.3% | 54,020 | +341.0% | 0.01% | +60.0% |
| Q2 2013 | $214,000 | – | 12,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |